PO.CL11.01 · 临床研究
Biological and Clinical Consequences of Cancer Therapy
20 张海报
19 张含 PDF
🕑 Apr 21 2026 9:00AM 📍 Section 41
-
5211 · PDF
Lung adenocarcinoma and urothelial carcinoma: Analysis of double cancer in Chang-Gung Medical Foundation
Feng-Che Kuan, Meng-Hung Lin, Chung-Sheng Shi
-
5212 · PDF
Clinical characterization of immune checkpoint inhibitor-induced myocarditis and the triple M overlap syndrome
Hassan Mohammed Abushukair, Eman Alghamdi, Woncheol Jung, Mehak Laharwal, Hafsa Gundroo, Sagal Pannu, Aik Choon Tan, Pauline Funchain, Noha Abdel-Wahab, Elad Sharon, Douglas B. Johnson, Amin H. Nassar, Fawaz Al-Harbi, Tae Gyu Oh, Abdul Rafeh Naqash
-
5213 · PDF
T-cell transcriptome affected by therapy-related clonal hematopoiesis in long-term survivors of pediatric cancers
Nadezhda V. Terekhanova, Sivaraman Natarajan, Bensheng Ju, Kohei Hagiwara, Li Dong, Zhaoming Wang, Leslie L. Robison, John Easton, Jinghui Zhang
-
5214 · PDF
The mutational landscape underlying the late effects of anthracyclines on tumor, blood, and heart genomes
Mathepan Jeya Mahendralingam, Mehdi Layeghifard, Timmy Wen, Burçak Otlu, Seema Mital, Filio Billia, Adam Shlien
-
5215 · PDF
Metabolic and lipidomic changes in early asparaginase hepatotoxicity in mice
Veronica Ruiz-Torres, Jennifer J. Chia, Michael D. Cohen, Jia Tan, Kevin J. Williams, Nedas Matulionis, Abby Krall, Heather R. Christofk, Etan Orgel, Steven D. Mittelman
-
5216 · PDF
Novel transdermal curcumin attenuates cisplatin induced neuropathy in a mouse model of breast cancer
Yugal Goel, Carolina Mireles, Dahlia Ordaz, Kendall O’Daniel, Kristen A. Peterson, Naomi Lomeli, Reina Lomeli, Daniela A. Bota, Joel Friedman, Kalpna Gupta
-
5217 · PDF
Mast cell activation leads to cisplatin-induced peripheral neuropathy
Carolina Mireles, Donovan A. Argueta, Raghda Fouda, Sonal Joshi, Daniela A. Bota, Kalpna Gupta
-
5218 · PDF
Leveraging a PARP inhibitor as neuroprotection against chemotherapy induced cognitive impairments
Dahlia A. Ordaz, Shashi Jain, Daniela A. Bota
-
5219 · PDF
Systemic therapy and cardiovascular disease in adolescent and young adult breast cancer survivors
Theresa H. M. Keegan, Candice A. M. Sauder, Ann M. Brunson, Renata Abrahao, Anne C. Kirchhoff, Eric Haupt, Mallory Casperson, Ted Wun, Chun R. Chao, Andrew B. Smitherman, Hazel B. Nichols, Jessica Chubak, Erin E. Hahn, Lawrence H. Kushi, Kathryn J. Ruddy
-
5220 · PDF
Association between metabolic syndrome and risk of second primary malignancy among patients with a history of cancer
Pragati Advani, Nicolas F. Schlecht, Christina Crabtree-Ide, Sarah Mullin, Oday Karadsheh, Tessa Faye Flores, Han Yu, Kayla Catalfamo, Mary E. Reid, Sai Yendamuri
-
5221 · PDF
Racial/ethnic disparities in risk of second primary malignancy among women in the Pathways Study of breast cancer survivors
Pragati Gole Advani, Lia D’Addario, Cecile A. Laurent, Janise M. Roh, Marilyn L. Kwan, Theresa H. Keegan, Isaac J. Ergas, Scarlett L. Gomez, Han Yu, Christine B. Ambrosone, Lawrence H. Kushi
-
5222 · PDF
Multifactorial risks for multiple primary cancers
Johnathan Amsalem, Ying Liu, Aliya Khurram, Yelena Kemel, Andrew Marderstein, Mitul Waghmare, Semanti Mukherjee, Michael Conry, Vignesh Ravichandran, Saibaba Magunta, Ritika Kundra, Matthew Buas, Christopher Fong, Justin Jee, Michael Berger, Jian Carrot-Zhang, Zsofia Stadler, Venkatraman Seshan, Nikolaus Schultz, Kenneth Offit, Vijai Joseph
-
5223
Risk factors for early locoregional recurrence among young-onset breast cancer patients: Findings from a single institutional prospective dataset
Kristen D. Brantley, Tonia Parker, Julie Vincuilla, Alyssa R. Martin, Elizabeth A. Mittendorf, Catherine Stever, Craig Snow, Rebecca A. Ottesen, Sara M. Tolaney, Tari A. King, Nancy U. Lin, Ann H. Partridge
-
5224 · PDF
Shifting the gut microbiome to alleviate anti-cancer treatment-induced cardiovascular toxicity
Zipporah Cornelius, Adam Wilson, Valerie Payne, Eleanor Cyrus, Kenysha YJ. Clear, David R. Soto-Pantoja, Katherine L. Cook
-
5225 · PDF
Is endothelial dysfunction induced by aromatase inhibitors reversible after treatment?
Mohamed Dabour, Adnan Shaaban, Jack Wolf, Daniel Duprez, Douglas Yee, Beshay Zordoky, Anne Blaes
-
5226 · PDF
The role of pancreatic adenocarcinoma cancer-stromal interactions on cardiac structure and function
Anna E. Gibson, Praveen Bhoopathi, Adolfo Mauro, Eleonora Mezzaroma, Vignesh Vudatha, Arunima Punjala, Vashti L. Bandy, Fadi Salloum, Jose G. Trevino
-
5227 · PDF
Clone wars: Evidence of clonal stability in a longitudinal prospective cohort of cancer survivors with serial NGS analysis
Anmol Goyal, Akriti Jain, Salendra Singh, Ying Ni, Emmett Samsa, Kristen Sykes, Sujata Patil, Abhay Singh
-
5229 · PDF
Hair loss in cancer patients receiving small molecule inhibitors: Evidence from clinical trials
Isabella Kamholtz, Simonetta I. Gaumond, Joaquin Jimenez
-
5230 · PDF
Alopecia in cancer immunotherapy: Incidence and patterns with monoclonal antibodies and antibody-drug conjugates
Isabella Kamholtz, Simonetta I. Gaumond, Joaquin Jimenez
-
5231 · PDF
GAS6 signaling links smoke-filled environments to increased invasion and communication in gastric and lung cancer models
Emilee N. Humphreys, Derek Clarke, Kristen Noyes, Madeline Boyer, Juan Arroyo, Amber Gonda
在完整检索应用中浏览本分会场 →